Skip to content

References

  1. VanFrank B, Malarcher A, Cornelius ME, Schecter A, Jamal A, Tynan M. Adult smoking cessation, United States, 2022. MMWR Morb Mortal Wkly Rep. 2024;73(29):633-641.
  2. U.S. Department of Health and Human Services. The Health Consequences of Smoking, 50 Years of Progress: A Report of the Surgeon General. Atlanta, GA: Centers for Disease Control and Prevention, Office on Smoking and Health; 2014.
  3. Agaku I. Tobacco product use among U.S. adults, 2023–2024. NEJM Evid. 2026. doi:10.1056/EVIDpha2500339.
  4. World Health Organization. Tobacco [fact sheet]. Geneva: World Health Organization; June 2025.
  5. Centers for Disease Control and Prevention. Economic trends in tobacco. Office on Smoking and Health. Accessed October 19, 2026. https://www.cdc.gov/tobacco/php/data-statistics/economic-trends/index.html
  6. U.S. Department of Health and Human Services. Smoking Cessation: A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2020.
  7. World Health Organization. WHO Tobacco Knowledge Summaries: Tobacco and Postsurgical Outcomes. Geneva: World Health Organization; 2020.
  8. Cinciripini PM, Kypriotakis G, Blalock JA, et al. Survival outcomes of an early intervention smoking cessation treatment after a cancer diagnosis. JAMA Oncol. 2024. doi:10.1001/jamaoncol.2024.4890.
  9. U.S. Food and Drug Administration. Approval letter, NDA 021928, Chantix (varenicline) tablets. May 10, 2006.
  10. Rigotti NA, Benowitz NL, Prochaska J, et al. Cytisinicline for smoking cessation: a randomized clinical trial. JAMA. 2023;330(2):152-160.
  11. Rigotti NA, Benowitz NL, Prochaska JJ, et al. Cytisinicline for smoking cessation: the ORCA phase 3 replication randomized clinical trial. JAMA Intern Med. 2025. doi:10.1001/jamainternmed.2025.0628.
  12. Rigotti NA, Benowitz NL, Prochaska JJ, et al. Cytisinicline for vaping cessation in adults using nicotine e-cigarettes: the ORCA-V1 randomized clinical trial. JAMA Intern Med. 2024;184(8):922-930.
  13. Data on file. Achieve Life Sciences, Inc.
  14. Benowitz NL. Nicotine addiction. N Engl J Med. 2010;362(24):2295-2303.
  15. Mitchell Nides, Nancy A Rigotti, Neal Benowitz, Anthony Clarke, Cindy Jacobs, A Multicenter, Double-Blind, Randomized, Placebo-Controlled Phase 2b Trial of Cytisinicline in Adult Smokers (The ORCA-1 Trial), Nicotine & Tobacco Research, Volume 23, Issue 10, October 2021, Pages 1656–1663, https://doi.org/10.1093/ntr/ntab073